Featured Research

from universities, journals, and other organizations

Adrenaline given before snakebite anti-venom treatment reduces allergic reactions, study finds

Date:
May 11, 2011
Source:
Public Library of Science
Summary:
Giving low-dose adrenaline to patients who have been bitten by a poisonous snake before treatment with the appropriate anti-venom is safe and reduces the risk of acute severe reactions to the treatment, but giving promethazine has no such effect and giving hydrocortisone may actually be harmful, new research finds.

Giving low-dose adrenaline to patients who have been bitten by a poisonous snake before treatment with the appropriate antivenom is safe and reduces the risk of acute severe reactions to the treatment, but giving promethazine has no such effect and giving hydrocortisone may actually be harmful. These findings from a study led by Asita De Silva from the Clinical Trials Unit, Faculty of Medicine, University of Kelaniya in Ragama, Sri Lanka, are important because in some countries where snake bites are a major health problem, acute allergic reactions to poor quality antivenoms are common and often fatal.

In a study involving more than 1000 people who were admitted to five hospitals in Sri Lanka after experiencing a snakebite, the authors randomized patients to receive low-dose adrenaline, promethazine, hydrocortisone or placebo -- alone and in all possible combinations -- immediately before treatment with an antivenom infusion. Compared with placebo, pretreatment with adrenaline reduced severe reactions to the antivenom by 43% at one hour and by 38% over 48 hours. By contrast, neither hydrocortisone nor promethazine given alone reduced the rate of adverse reactions to the antivenom and adding hydrocortisone appeared to negate the beneficial effect of adrenaline. These findings also emphasize the high rate of acute adverse reactions to antivenom and stress the importance of improving the quality of the available antivenoms in Sri Lanka and South Asia.

The authors say: "The need for concerted action by local health and regulatory authorities, the World Health Organization, and other stakeholders, including technology transfer programmes between antivenom manufacturers, to improve the quality of antivenom can not be overemphasized."

They continue: "Until these overdue improvements come about, we have shown that pretreatment with low-dose adrenaline is an effective and safe therapy to prevent acute reactions to antivenom… Meanwhile, we continue to reiterate that the need for careful observation of patients receiving antivenom and prompt treatment of acute reactions when they occur remains undiminished."


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. H. Asita de Silva, Arunasalam Pathmeswaran, Channa D. Ranasinha, Shaluka Jayamanne, Senarath B. Samarakoon, Ariyasena Hittharage, Ranjith Kalupahana, G. Asoka Ratnatilaka, Wimalasiri Uluwatthage, Jeffrey K. Aronson, Jane M. Armitage, David G. Lalloo, H. Janaka de Silva. Low-Dose Adrenaline, Promethazine, and Hydrocortisone in the Prevention of Acute Adverse Reactions to Antivenom following Snakebite: A Randomised, Double-Blind, Placebo-Controlled Trial. PLoS Medicine, 2011; 8 (5): e1000435 DOI: 10.1371/journal.pmed.1000435

Cite This Page:

Public Library of Science. "Adrenaline given before snakebite anti-venom treatment reduces allergic reactions, study finds." ScienceDaily. ScienceDaily, 11 May 2011. <www.sciencedaily.com/releases/2011/05/110510175159.htm>.
Public Library of Science. (2011, May 11). Adrenaline given before snakebite anti-venom treatment reduces allergic reactions, study finds. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2011/05/110510175159.htm
Public Library of Science. "Adrenaline given before snakebite anti-venom treatment reduces allergic reactions, study finds." ScienceDaily. www.sciencedaily.com/releases/2011/05/110510175159.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Poses Little Threat To U.S.: CDC

Ebola Outbreak Poses Little Threat To U.S.: CDC

Newsy (July 29, 2014) The Ebola outbreak in West Africa poses little threat to Americans, according to officials with the Centers for Disease Control and Prevention. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins